SonoScape Medical Corp
SZSE:300633

Watchlist Manager
SonoScape Medical Corp Logo
SonoScape Medical Corp
SZSE:300633
Watchlist
Price: 25.65 CNY -3.72%
Market Cap: ¥11.1B

SonoScape Medical Corp
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

SonoScape Medical Corp
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
SonoScape Medical Corp
SZSE:300633
Cash from Operating Activities
-¥48.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Cash from Operating Activities
¥967.8m
CAGR 3-Years
38%
CAGR 5-Years
46%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Cash from Operating Activities
¥1.4B
CAGR 3-Years
-19%
CAGR 5-Years
-7%
CAGR 10-Years
8%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Cash from Operating Activities
¥10.1B
CAGR 3-Years
-6%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Andon Health Co Ltd
SZSE:002432
Cash from Operating Activities
¥257.6m
CAGR 3-Years
-76%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Cash from Operating Activities
-¥619m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

SonoScape Medical Corp
Glance View

Market Cap
11.1B CNY
Industry
Health Care

SonoScape Medical Corp, a company entrenched in the realm of medical technology, weaves its story around innovation and dedication in the healthcare sector. Founded in 2002, this Shenzhen-based company has become a global player in the development and production of medical equipment, particularly in the field of ultrasound and endoscopy. At its core, SonoScape melds cutting-edge technology with practical healthcare applications, aiming to improve diagnostic accuracy and patient outcomes. With its R&D centers rich in technical prowess and creativity, SonoScape continuously pushes forward the boundaries of medical imaging, offering a diverse range of ultrasound systems that cater to various clinical needs and environments. Revenue for SonoScape Medical Corp stems largely from the sale of these high-precision medical devices, which are marketed both domestically within China and internationally. The company thrives on the ever-growing demand for advanced healthcare solutions, ensuring a steady stream of income through its robust distribution channels across numerous countries. In addition to equipment sales, SonoScape provides comprehensive after-sales service packages, ensuring customer satisfaction and fostering long-term relationships with healthcare institutions. By maintaining a strong focus on innovation while meeting industry standards and regulations, SonoScape not only solidifies its financial standing but also enhances its reputation as a significant contributor to the global healthcare landscape.

Intrinsic Value
28.16 CNY
Undervaluation 9%
Intrinsic Value
Price ¥25.65

See Also

What is SonoScape Medical Corp's Cash from Operating Activities?
Cash from Operating Activities
-48.2m CNY

Based on the financial report for Dec 31, 2025, SonoScape Medical Corp's Cash from Operating Activities amounts to -48.2m CNY.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett